{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:32:11Z","timestamp":1762522331144,"version":"3.37.3"},"reference-count":48,"publisher":"Veterinary World","issue":"10","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"am","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"tdm","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["275\/2014"],"award-info":[{"award-number":["275\/2014"]}],"id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet World"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:p>Background and Aim: Middle East respiratory syndrome coronavirus (MERS-CoV) has rapidly spread throughout the Middle East since its discovery in 2012. The virus poses a significant global public health threat with potentially devastating effects. In this study, a recombinant adenoviral-based vaccine encoding the spike 1 (S1) subunit of the MERS-CoV genome was constructed, and its humoral, and cellular immune responses were evaluated in mice.\n\nMaterials and Methods: Mice were immunized initially by intramuscular injection and boosted 3 weeks later by intranasal application. Expression of the S1 protein in the lungs and kidneys was detected using conventional polymerase chain reaction (PCR) and immunohistochemistry (IHC) targeting specific regions within the S1 subunit at weeks 3, 4, 5, and 6 after the first vaccination. Antigen-specific humoral and cellular immune responses were evaluated in serum and in cell culture following in vitro stimulation with a specific 9-mer epitope within the S1 protein (CYSSLILDY).\n\nResults: S1 protein expression was only detected by IHC in the kidneys of the Ad-MERS-S1 group at week 6 from first immunization, and in both lungs and kidneys of Ad-MERS-S1 group by conventional PCR at weeks 3 and 5 post-prime. The vaccine elicited a specific S1-immunoglobulin G antibody response, which was detected in the sera of the vaccinated mice at weeks 4 and 6 from the onset of the first immunization. There was a significant increase in the amount of Th1-related cytokines (interferon-\u03b3 and interleukin [IL] 12), and a significant decrease in the Th2-related cytokine IL-4 in splenocyte cell culture of the vaccinated group compared with the control groups.\n\nConclusion: The results of this study suggest that this recombinant adenovirus vaccine encoding the S1 subunit of MERS-CoV elicits potentially protective antigen-specific humoral and cellular immune responses in mice. This study demonstrates a promising vaccine for the control and\/or prevention of MERS-CoV infection in humans.<\/jats:p>","DOI":"10.14202\/vetworld.2019.1554-1562","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T08:56:39Z","timestamp":1570784199000},"page":"1554-1562","source":"Crossref","is-referenced-by-count":18,"title":["Recombinant adenoviral vaccine encoding the spike 1 subunit of the Middle East Respiratory Syndrome Coronavirus elicits strong humoral and cellular immune responses in mice"],"prefix":"10.14202","volume":"12","author":[{"given":"Mustafa","family":"Ababneh","sequence":"first","affiliation":[{"name":"Department of Basic Medical Veterinary Sciences, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu'men","family":"Alrwashdeh","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Veterinary Sciences, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Khalifeh","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Veterinary Sciences, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5308","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D. and Fouchier, R.A. (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med., 367(19): 1814-1820.","DOI":"10.1056\/nejmoa1211721"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Al-Tawfiq, J.A. and Memish, Z.A. (2014) Middle East respiratory syndrome coronavirus: Transmission and phylogenetic evolution. Trends Microbiol., 22(10): 573-579.","DOI":"10.1016\/j.tim.2014.08.001"},{"key":"ref2","unstructured":"Raj, V.S., Osterhaus, A.D., Fouchier, R.A. and Haagmans, B.L. (2014) MERS: Emergence of a novel human coronavirus. Curr. Opin. Virol., 5: 58-62."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Banik, G.R., Khandaker, G. and Rashid, H. (2015) Middle East respiratory syndrome coronavirus \u201cMERS-CoV\u201d: Current knowledge gaps. Paediatr. Respir. Rev., 16(3): 197-202.","DOI":"10.1016\/j.prrv.2015.04.002"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T.M., Raj, V.S., Zaki, A.M., Osterhaus, A.D., Haagmans, B.L., Gorbalenya, A.E., Snijder, E.J. and Fouchier, R.A. (2012) Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio, 3(6): e00473.","DOI":"10.1128\/mbio.00473-12"},{"key":"ref5","unstructured":"Jamil, B. and Habib, K. (2013) MERS-CoV--are we on the verge of a pandemic? J. Pak. Med. Assoc., 63(11): 1329-1331."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Reusken, C.B., Ababneh, M., Raj, V.S., Meyer, B., Eljarah, A., Abutarbush, S., Godeke, G.J., Bestebroer, T.M., Zutt, I., Muller, M.A., Bosch, B.J., Rottier, P.J., Osterhaus, A.D., Drosten, C., Haagmans, B.L. and Koopmans, M.P. (2013) Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill., 18(50): 20662.","DOI":"10.2807\/1560-7917.es2013.18.50.20662"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Hemida, M.G., Perera, R.A., Wang, P., Alhammadi, M.A., Siu, L.Y., Li, M., Poon, L.L., Saif, L., Alnaeem, A. and Peiris, M. (2013) Middle East respiratory syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill., 18(50): 20659.","DOI":"10.2807\/1560-7917.es2013.18.50.20659"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Haagmans, B.L., Al Dhahiry, S.H., Reusken, C.B., Raj, V.S., Galiano, M., Myers, R., Godeke, G.J., Jonges, M., Farag, E., Diab, A., Ghobashy, H., Alhajri, F., Al-Thani, M., Al-Marri, S.A., Al Romaihi, H.E., Al Khal, A., Bermingham, A., Osterhaus, A.D., Al Hajri, M.M. and Koopmans, M.P. (2014) Middle East respiratory syndrome coronavirus in dromedary camels: An outbreak investigation. Lancet Infect. Dis., 14(2): 140-145.","DOI":"10.1016\/s1473-3099(13)70690-x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Meyer, B., Muller, M.A., Corman, V.M., Reusken, C.B., Ritz, D., Godeke, G.J., Lattwein, E., Kallies, S., Siemens, A., van Beek, J., Drexler, J.F., Muth, D., Bosch, B.J., Wernery, U., Koopmans, M.P., Wernery, R. and Drosten, C. (2014) Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg. Infect. Dis., 20(4): 552-559.","DOI":"10.3201\/eid2004.131746"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Azhar, E.I., Hashem, A.M., El-Kafrawy, S.A., Sohrab, S.S., Aburizaiza, A.S., Farraj, S.A., Hassan, A.M., Al-Saeed, M.S., Jamjoom, G.A. and Madani, T.A. (2014) Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient. MBio, 5(4): e01450-01414.","DOI":"10.1128\/mbio.01450-14"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"See, R.H., Petric, M., Lawrence, D.J., Mok, C.P., Rowe, T., Zitzow, L.A., Karunakaran, K.P., Voss, T.G., Brunham, R.C., Gauldie, J., Finlay, B.B. and Roper, R.L. (2008) Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines. J. Gen. Virol., 89(Pt 9): 2136-2146.","DOI":"10.1099\/vir.0.2008\/001891-0"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Guo, X., Deng, Y., Chen, H., Lan, J., Wang, W., Zou, X., Hung, T., Lu, Z., and Tan, W. (2015) Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus Type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Immunology, 145(4): 476-484.","DOI":"10.1111\/imm.12462"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Kim, E., Okada, K., Kenniston, T., Raj, V.S., Al Hajri, M.M., Farag, E.A., Al Hajri, F., Osterhaus, A.D., Haagmans, B.L. and Gambotto, A. (2014) Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB\/c mice. Vaccine, 32(45): 5975-5982.","DOI":"10.1016\/j.vaccine.2014.08.058"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Song, F., Fux, R., Provacia, L.B., Volz, A., Eickmann, M., Becker, S., Osterhaus, A.D., Haagmans, B.L. and Sutter, G. (2013) Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies. J Virol., 87(21): 11950-11954.","DOI":"10.1128\/jvi.01672-13"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Volz, A., Kupke, A., Song, F., Jany, S., Fux, R., Shams-Eldin, H., Schmidt, J., Becker, C., Eickmann, M., Becker, S. and Sutter, G. (2015) Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein. J. Virol., 89(16): 8651-8656.","DOI":"10.1128\/jvi.00614-15"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Jung, S.Y., Kang, K.W., Lee, E,Y., Seo, D.W., Kim, H.L., Kim, H., Kwon, T., Park, H.L., Kim, H., Lee, S.M. and Nam, J.H. (2018) Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Vaccine, 36(24): 3468-3476.","DOI":"10.1016\/j.vaccine.2018.04.082"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Langenmayer, M.C., Lulf-Averhoff, A.T., Adam-Neumair, S., Fux, R., Sutter, G. and Volz, A. (2018) Distribution and absence of generalized lesions in mice following single-dose intramuscular inoculation of the vaccine candidate MVA-MERS-S. Biologicals, 54: 58-62.","DOI":"10.1016\/j.biologicals.2018.05.004"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Ozharovskaia, T.A., Zubkova, O.V., Dolzhikova, I.V., Gromova, A.S., Grousova, D.M., Tukhvatulin, A.I., Popova, O., Shcheblyakov, D.V., Scherbinin, D.N., Dzharullaeva, A.S., Erokhova, A.S., Shmarov, M.M., Loginova, S.Y., Borisevich, S.V., Naroditsky, B.S., Logunov, D.Y. and Gintsburg, A.L. (2019) Immunogenicity of different forms of Middle East respiratory syndrome s glycoprotein. Acta Naturae, 11(1): 38-47.","DOI":"10.32607\/20758251-2019-11-1-38-47"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Alharbi, N.K., Padron-Regalado, E., Thompson, C.P., Kupke, A., Wells, D., Sloan, M.A., Grehan, K., Temperton, N., Lambe, T., Warimwe, G., Becker, S., Hill, A.V.S. and Gilbert, S.C. (2017) ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. Vaccine, 35(30): 3780-3788.","DOI":"10.1016\/j.vaccine.2017.05.032"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Munster, V.J., Wells, D., Lambe, T., Wright, D., Fischer, R.J., Bushmaker, T., Saturday, G., van Doremalen, N., Gilbert, S.C., de Wit, E. and Warimwe, G.M. (2017) Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model. NPJ Vaccines, 2: 28.","DOI":"10.1038\/s41541-017-0029-1"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Jia, W., Channappanavar, R., Zhang, C., Li, M., Zhou, H., Zhang, S., Zhou, P., Xu, J., Shan, S., Shi, X., Wang, X., Zhao, J., Zhou, D., Perlman, S. and Zhang, L. (2019) Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection. Emerg. Microbes Infect., 8(1): 760-772.","DOI":"10.1080\/22221751.2019.1620083"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Hashem, A.M., Algaissi, A., Agrawal, A., Al-Amri, S.S., Alhabbab, R.Y., Sohrab, S.S., Almasoud, A., Alharbi, N.K., Peng, B.H., Russell, M., Li, X. and Tseng, C.T.K. (2019) A highly immunogenic, protective and safe adenovirus-based vaccine expressing MERS-CoV S1-CD40L fusion protein in transgenic human DPP4 mouse model. J. Infect. Dis., : jiz137.","DOI":"10.1093\/infdis\/jiz137"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Raj, V.S., Mou, H., Smits, S.L., Dekkers, D.H., Muller, M.A., Dijkman, R., Muth, D., Demmers, J.A., Zaki, A., Fouchier, R.A., Thiel, V., Drosten, C., Rottier, P.J., Osterhaus, A.D., Bosch, B.J. and Haagmans, B.L. (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature, 495(7440): 251-254.","DOI":"10.1038\/nature12005"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Zhou, N., Zhang, Y., Zhang, J.C., Feng, L. and Bao, J.K. (2014) The receptor-binding domain of MERS-CoV: The dawn of vaccine and treatment development. J. Formos. Med. Assoc., 113(3): 143-147.","DOI":"10.1016\/j.jfma.2013.11.006"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Liu, R.Y., Wu, L.Z., Huang, B.J., Huang, J.L., Zhang, Y.L., Ke, M.L., Wang, J.M., Tan, W.P., Zhang, R.H., Chen, H.K., Zeng, Y.X. and Huang, W. (2005) Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats. Virus Res., 112(1-2): 24-31.","DOI":"10.1016\/j.virusres.2005.02.009"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"See, R.H., Zakhartchouk, A.N., Petric, M., Lawrence, D.J., Mok, C.P., Hogan, R.J., Rowe, T., Zitzow, L.A., Karunakaran, K.P., Hitt, M.M., Graham, F.L., Prevec, L., Mahony, J.B., Sharon, C., Auperin, T.C., Rini, J.M., Tingle, A.J., Scheifele, D.W., Skowronski, D.M., Patrick, D.M., Voss, T.G., Babiuk, L.A., Gauldie, J., Roper, R.L., Brunham, R.C. and Finlay, B.B. (2006) Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus. J. Gen. Virol., 87(Pt 3): 641-650.","DOI":"10.1099\/vir.0.81579-0"},{"key":"ref27","unstructured":"Vector Biolabs. (2016) (The Gene Delivery Company): Recombinant Adenovirus Construction. Available from: https:\/\/www.vectorbiolabs.com\/vbs\/page.html?m=82.  Last accessed on 14-08-2019."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Alagaili, A.N., Briese, T., Mishra, N., Kapoor, V., Sameroff, S.C., Burbelo, P.D., de Wit, E., Munster, V.J., Hensley, L.E., Zalmout, I.S., Kapoor, A., Epstein, J.H., Karesh, W.B., Daszak, P., Mohammed, O.B. and Lipkin, W.I. (2014) Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio, 5(2): e00884-e00814.","DOI":"10.1128\/mbio.01002-14"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Fahmy, N., Woo, M., Alameldin, M., Lee, J.K., MacDonald, K., Goneau, L.W., Cadieux, P., Burton, J. and Pautler, S. (2014) Endogenous biotin expression in renal and testicular tumors and literature review. Can. Urol. Assoc. J., 8(7-8): 268-272.","DOI":"10.5489\/cuaj.1810"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Bussolati, G., Gugliotta, P., Volante, M., Pace, M. and Papotti, M. (1997) Retrieved endogenous biotin: A novel marker and a potential pitfall in diagnostic immunohistochemistry. Histopathology, 31(5): 400-407.","DOI":"10.1046\/j.1365-2559.1997.3020895.x"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Khalifeh, M.S. and Stabel, J.R. (2004) Effects of gamma interferon, interleukin-10, and transforming growth factor beta on the survival of Mycobacterium avium subsp. paratuberculosis in monocyte-derived macrophages from naturally infected cattle. Infect. Immun., 72(4): 1974-1982.","DOI":"10.1128\/iai.72.4.1974-1982.2004"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Ali, M.T., Morshed, M.M., Gazi, M.A., Musa, M.A., Kibria, M.G., Uddin, M.J., Khan, M.A. and Hasan, S. (2014) Computer-aided prediction and identification of potential epitopes in the receptor-binding domain (RBD) of spike (S) glycoprotein of MERS-CoV. Bioinformation, 10(8): 533-538.","DOI":"10.6026\/97320630010533"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25(4): 402-408.","DOI":"10.1006\/meth.2001.1262"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Skelding, K.A., Hickey, D.K., Horvat, J.C., Bao, S., Roberts, K.G., Finnie, J.M., Hansbro, P.M. and Beagley, K.W. (2006) Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection. Vaccine, 24(3): 355-366.","DOI":"10.1016\/j.vaccine.2005.07.104"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Wang, N., Shi, X., Jiang, L., Zhang, S., Wang, D., Tong, P., Guo, D., Fu, L., Cui, Y., Liu, X., Arledge, K.C., Chen, Y.H., Zhang, L. and Wang, X. (2013) Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res., 23(8): 986-993.","DOI":"10.1038\/cr.2013.92"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Du, L., Kou, Z., Ma, C., Tao, X., Wang, L., Zhao, G., Chen, Y., Yu, F., Tseng, C.T., Zhou, Y. and Jiang, S. (2013) A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: Implication for developing therapeutics and vaccines. PLoS One, 8(12): e81587.","DOI":"10.1371\/journal.pone.0081587"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Chan, R.W., Chan, M.C., Agnihothram, S., Chan, L.L., Kuok, D.I., Fong, J.H., Guan, Y., Poon, L.L., Baric, R.S., Nicholls, J.M. and Peiris, J.S. (2013) Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J. Virol., 87(12): 6604-6614.","DOI":"10.1128\/jvi.00009-13"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Eckerle, I., Muller, M.A., Kallies, S., Gotthardt, D.N. and Drosten, C. (2013) In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East respiratory syndrome (MERS) coronavirus infection. Virol. J., 10 : 359.","DOI":"10.1186\/1743-422x-10-359"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Lambeir, A.M., Durinx, C., Scharpe, S. and De Meester, I. (2003) Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci., 40(3): 209-294.","DOI":"10.1080\/713609354"},{"key":"ref40","unstructured":"Kidd, P. (2003) Th1\/Th2 balance: The hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev., 8(3): 223-246."},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Tatsis, N. and Ertl, H.C. (2004) Adenoviruses as vaccine vectors. Mol. Ther., 10(4): 616-629.","DOI":"10.1016\/j.ymthe.2004.07.013"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Santra, S., Seaman, M.S., Xu, L., Barouch, D.H., Lord, C.I., Lifton, M.A., Gorgone, D.A., Beaudry, K.R., Svehla, K., Welcher, B., Chakrabarti, B.K., Huang, Y., Yang, Z.Y., Mascola, J.R., Nabel, G.J. and Letvin, N.L. (2005) Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates. J. Virol., 79(10): 6516-6522.","DOI":"10.1128\/jvi.79.10.6516-6522.2005"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Ma, C., Li, Y., Wang, L., Zhao, G., Tao, X., Tseng, C.T., Zhou, Y., Du, L. and Jiang, S. (2014) Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines. Vaccine, 32(18): 2100-2108.","DOI":"10.1016\/j.vaccine.2014.02.004"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Josset, L., Menachery, V.D., Gralinski, L.E., Agnihothram, S., Sova, P., Carter, V.S., Yount, B.L., Graham, R.L., Baric, R.S. and Katze, M.G. (2013) Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. MBio, 4(3): e00165-00113.","DOI":"10.1128\/mbio.00165-13"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Yang, Y., Zhang, L., Geng, H., Deng, Y., Huang, B., Guo, Y., Zhao, Z. and Tan, W. (2013) The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell, 4(12): 951-961.","DOI":"10.1007\/s13238-013-3096-8"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Lau, S.K., Lau, C.C., Chan, K.H., Li, C.P., Chen, H., Jin, D.Y., Chan, J.F., Woo, P.C. and Yuen, K.Y. (2013) Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment. J. Gen. Virol., 94(Pt 12): 2679-2690.","DOI":"10.1099\/vir.0.055533-0"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Faure, E., Poissy, J., Goffard, A., Fournier, C., Kipnis, E., Titecat, M., Bortolotti, P., Martinez, L., Dubucquoi, S., Dessein, R., Gosset, P., Mathieu, D. and Guery, B. (2014) Distinct immune response in two MERS-CoV-infected patients: Can we go from bench to bedside? PLoS One., 9(2): e88716.","DOI":"10.1371\/journal.pone.0088716"}],"container-title":["Veterinary World"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.veterinaryworld.org\/Vol.12\/October-2019\/7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.12\/October-2019\/7.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.12\/October-2019\/7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T12:03:20Z","timestamp":1606737800000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.veterinaryworld.org\/Vol.12\/October-2019\/7.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":48,"issue-title":["October-2019"],"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]},"published-print":{"date-parts":[[2019,10]]}},"URL":"https:\/\/doi.org\/10.14202\/vetworld.2019.1554-1562","relation":{},"ISSN":["2231-0916","0972-8988"],"issn-type":[{"type":"electronic","value":"2231-0916"},{"type":"print","value":"0972-8988"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}